TOPRA discusses forthcoming Paediatrics Regulation

A session on the forthcoming Paediatrics Regulation, held at the TOPRA and EMEA joint meeting on 7th and 8th December, provided timely debate with publication of the regulation due before the end of the year.  In an extensive question and answer session, concerns were raised among attendees with regard to the delay of regulations.  However the delegates were appreciative of the preparatory planning work on this issue undertaken by the EMEA, led by Agnes St. Raymond.

Commenting on the importance of this session TOPRA President Axel Wenzel said, ‘Every regulatory affairs professional needs to understand the implications of this new regulation and the process around waivers and Paediatric Investigation Plans (PIPs).  We appreciated the EMEA’s insight and eagerly await the publication of the regulation.  Furthermore, we hope that our next meeting in Brussels in January will create similarly productive debate’.

This next meeting on Paediatrics Medicines is well-timed, following research undertaken by TOPRA highlighting the lack of knowledge throughout industry towards the forthcoming regulation.  The results of the research found that only 21.1% of industry is fully aware of the impact that the new Paediatric Regulation will have on their planned Marketing Authorisation Applications (MAAs). Moreover 30.3% is not at all aware of the opportunities from the new regulation for their existing MAs, with almost half of respondents (47.8%) only partially aware.

Note to Editor

For further information or comment contact:
Jacob Coy
Cicero Consulting
+44 20 7665 9530
+44 79 0039 2531

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Under 40s to be offered alternative to AstraZeneca COVID-19 vaccine

Under 40s to be offered alternative to AstraZeneca COVID-19 vaccine

Patients aged 30-39 will be offered an alternative to the Oxford/AstraZeneca COVID-19...

GPs per patient down 10% in just five years, NHS data reveal

GPs per patient down 10% in just five years, NHS data reveal

The number of fully-qualified, full-time equivalent (FTE) GPs per patient in England...

Supportive model must replace harmful CQC inspections, BMA chair warns

Supportive model must replace harmful CQC inspections, BMA chair warns

CQC inspections that ‘divert time away from patient care’ and ‘instil fear’ among...

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

A 'tsunami' of work is drowning general practice: GPs speak out about a profession at its limit

A 'tsunami' of work is drowning general practice: GPs speak out about a profession at its limit

Rocketing workloads created by huge backlogs of cases and continuing COVID-19 disruption...

Slight increase in GP workforce during past year, but number of partners continues to fall

Slight increase in GP workforce during past year, but number of partners continues to fall

The GP workforce grew by 0.4% in the year to March 2021, but the number of GP partners...